- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Kristen Renee Fournier
News 9 results
In the News · Source: Law360
October 14, 2021
Kristen Fournier counsels LTL Management, a subsidiary of Johnson & Johnson, in Chapter 11 proceedings
Recognition
June 10, 2021
Legal 500 United States 2021 Ranks King & Spalding Practices Among the Top in the Nation
Recognition
May 20, 2021
Chambers USA 2021 Names 179 K&S Lawyers and 65 K&S Practice Groups as Leaders in Their Fields
Recognition
December 11, 2020
BTI Consulting Names Eight King & Spalding Partners 2020 Client Service All-Stars
Events 4 results
Webinar
May 17, 2022
How PFAS Legal Issues Impact Companies in Real Life: Representative Case Studies
Webinar
November 9, 2021
King & Spalding Pharmaceutical University 2021
Speaking Engagement
December 7, 2020
Andy Bayman, Kristen Fournier, Adam Spicer to Speak on ACI’s Annual Conference on Drug & Medical Device Litigation
Webinar
May 18, 2020
Remote Judicial Proceedings: Is this the New Normal?
Insights 12 results
Newsletter
February 23, 2022
Focus on Forever– February 22, 2022
Client Alert
January 26, 2022
Spotlight on PFAS and Other Substances in Cosmetics Likely to Grow in 2022
Article · Source: Law360
January 25, 2022
How New Laws Could Tighten FDA Regulation Of Cosmetics
Newsletter
November 16, 2021
Focus on Forever - November 16, 2021